continuous bioprocessing market

1. Continuous Bioprocessing Market by Size, Share, Forecast, & Trends Analysis

2. Continuous Bioprocessing Market to reach $1.32 billion by 2031 Meticulous Research®– a leading global market research company published a research report titled “Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography - Forecast to 2028”. Download free Sample Report Here: https://www.meticulousresearch.com/download-sample- report/cp_id=5079 According to this latest publication from Meticulous Research®, the continuous bioprocessing market is expected to grow at a CAGR of 23.0% from $100.75 million in 2021 to $429.12 million by 2028. The growth in the overall continuous bioprocessing market is mainly attributed to the growing demand for biopharmaceuticals, growing development of new technologies and products related to continuous bioprocessing, and rising government support for biopharmaceutical manufacturing. In addition, significant opportunities from emerging Asia- Pacific and Latin American regions and growing approval for personalized medicines further support this market's growth. However, factors such as the high risk of contamination with continuous bioprocessing, the complex and technically unfeasible nature of continuous bioprocessing in downstream processes, and shortage of bioprocessing professionals are expected to hinder the adoption of continuous bioprocessing. Continuous Bioprocessing Market: Future Outlook The global continuous bioprocessing market study presents historical market data in terms of values (2019 and 2020), estimated current data (2021), and forecasts it for 2028– Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography. The study also evaluates industry competitors and analyzes their market share at the global and regional levels. Browse in depth: https://www.meticulousresearch.com/product/continuous-bioprocessing-market-5079 Based on product, the filtration systems and consumables segment accounted for the largest share of the market in 2020. The growing demand for higher standards of filter operations in biopharma manufacturing is one of the major drivers for the growth of this segment. Filter Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Continuous Bioprocessing Market to reach $1.32 billion by 2031 manufacturers are developing filtration technologies for continuous bioprocessing to achieve both separation and purification through a combination of physical removal capabilities of filtration and size exclusion. Based on application, the research and development segment is expected to grow at the highest CAGR during the forecast period. The rising focus of R&D to develop vaccines and suitable therapies for COVID-19 and growing relevance of mAb manufacturing for the treatment of various diseases are driving the market growth. The R&D in cell and gene therapy is also accelerated, with over 900 candidates in clinical studies. Facility expansions of CROs or CDMOs to advance research in these areas are expected to boost market growth. Continuous bioprocessing consists of integrated continuous unit processes without intermediate holding tanks through which product travels into containers in a constant flow. Continuous unit operations are characterized by extremely intensified processing with short downtimes. An end-to-end bioprocess involves a perfusion bioreactor, multi-column chromatography systems, and multi-column pharmaceutical and biopharmaceutical manufacturers adopt a hybrid approach for continuous biopharmaceutical manufacturing in which only the upstream or downstream process is continuous. intermediate purification. Some Download request sample report here; https://www.meticulousresearch.com/request-sample- report/cp_id=5079 Based on end user, the CDMOs and CROs segment is expected to grow at the highest CAGR during the forecast period. Rising investments in CDMOs and CROs and the gradual shifting of CDMOs from batch to continuous manufacturing are driving the market growth. This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and the Middle East & Africa. In 2020, North America commanded the largest share of the global continuous bioprocessing market, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The key players operating in the continuous bioprocessing market are 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Continuous Bioprocessing Market to reach $1.32 billion by 2031 Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet (Spain). Quick Buy: https://www.meticulousresearch.com/Checkout/13717155 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Related reports: 1. Asia-Pacific Continuous Bioprocessing Market: https://www.meticulousresearch.com/download-sample-report/cp_id=5682 2.Europe Continuous Bioprocessing Market: https://www.meticulousresearch.com/download-sample-report/cp_id=5605 3.Continuous Glucose Monitoring Market: https://www.meticulousresearch.com/download-sample-report/cp_id=5960 Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com